These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1400172)

  • 21. Phage-induced changes in Vibrio cholerae: serotype and biotype conversions.
    Ogg JE; Shrestha MB; Poudayl L
    Infect Immun; 1978 Jan; 19(1):231-8. PubMed ID: 75188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in gene expression between the classical and El Tor biotypes of Vibrio cholerae O1.
    Beyhan S; Tischler AD; Camilli A; Yildiz FH
    Infect Immun; 2006 Jun; 74(6):3633-42. PubMed ID: 16714595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor.
    Voss E; Manning PA; Attridge SR
    Microb Pathog; 1996 Mar; 20(3):141-53. PubMed ID: 8965675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical and El Tor biotypes of Vibrio cholerae differ in timing of transcription of tcpPH during growth in inducing conditions.
    Murley YM; Behari J; Griffin R; Calderwood SB
    Infect Immun; 2000 May; 68(5):3010-4. PubMed ID: 10769005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTXphi immunity: application in the development of cholera vaccines.
    Kimsey HH; Waldor MK
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7035-9. PubMed ID: 9618534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139.
    Jouravleva EA; McDonald GA; Marsh JW; Taylor RK; Boesman-Finkelstein M; Finkelstein RA
    Infect Immun; 1998 Jun; 66(6):2535-9. PubMed ID: 9596713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel ctxB variants of Vibrio cholerae O1 isolates, China.
    Zhang P; Zhou H; Kan B; Wang D
    Infect Genet Evol; 2013 Dec; 20():48-53. PubMed ID: 23954417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O antigen is the receptor of Vibrio cholerae serogroup O1 El Tor typing phage VP4.
    Xu J; Zhang J; Lu X; Liang W; Zhang L; Kan B
    J Bacteriol; 2013 Feb; 195(4):798-806. PubMed ID: 23222721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of temperate phage in determining lytic phage sensitivity and serotype of Vibrio cholerae.
    Siddiqui KA; Bhattacharyya FK
    Infect Immun; 1982 Sep; 37(3):847-51. PubMed ID: 7129638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vibrio cholerae classical biotype is converted to the viable non-culturable state when cultured with the El Tor biotype.
    Pradhan S; Mallick SK; Chowdhury R
    PLoS One; 2013; 8(1):e53504. PubMed ID: 23326443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,3-butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype.
    Yoon SS; Mekalanos JJ
    Infect Immun; 2006 Dec; 74(12):6547-56. PubMed ID: 17015461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DNA polymorphism of Vibrio cholera and other vibrios].
    Wang J; Yu X; Bai W
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):938-40. PubMed ID: 11715512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the Vibrio cholerae El Tor lipase operon lipAB and a protease gene downstream of the hly region.
    Ogierman MA; Fallarino A; Riess T; Williams SG; Attridge SR; Manning PA
    J Bacteriol; 1997 Nov; 179(22):7072-80. PubMed ID: 9371455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An experimental study of phage mediated bactericidal selection & emergence of the El Tor Vibrio cholerae.
    Zahid MS; Waise Z; Kamruzzaman M; Ghosh AN; Nair GB; Khairul Bashar SA; Mekalanos JJ; Faruque SM
    Indian J Med Res; 2011 Feb; 133(2):218-24. PubMed ID: 21415498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A PolyQ Membrane Protein of Vibrio cholerae Acts as the Receptor for Phage Infection.
    Fan F; Li Z; Wang J; Diao B; Liang W; Kan B
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and detection of different biotype-associated cell-bound haemagglutinins of Vibrio cholerae O1.
    Jonson G; Sanchez J; Svennerholm AM
    J Gen Microbiol; 1989 Jan; 135(1):111-20. PubMed ID: 2674322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-step processing for activation of the cytolysin/hemolysin of Vibrio cholerae O1 biotype El Tor: nucleotide sequence of the structural gene (hlyA) and characterization of the processed products.
    Yamamoto K; Ichinose Y; Shinagawa H; Makino K; Nakata A; Iwanaga M; Honda T; Miwatani T
    Infect Immun; 1990 Dec; 58(12):4106-16. PubMed ID: 2174833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel coordination of lipopolysaccharide modifications in Vibrio cholerae promotes CAMP resistance.
    Herrera CM; Henderson JC; Crofts AA; Trent MS
    Mol Microbiol; 2017 Nov; 106(4):582-596. PubMed ID: 28906060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB.
    Matson JS; Yoo HJ; Hakansson K; Dirita VJ
    J Bacteriol; 2010 Apr; 192(8):2044-52. PubMed ID: 20154134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.